株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

マイクロキャリアの世界市場 - 成長、動向、予測(2019年~2024年)

Microcarrier Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 910267
出版日 ページ情報 英文 102 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.91円で換算しております。
Back to Top
マイクロキャリアの世界市場 - 成長、動向、予測(2019年~2024年) Microcarrier Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年11月01日 ページ情報: 英文 102 Pages
概要

世界のマイクロキャリア市場は、細胞ベースワクチンおよび治療薬の需要の増加、生物学的製剤およびバイオシミラー産業の急成長、細胞療法研究の資金調達の増加などによって成長が促進されています。

当レポートでは、世界のマイクロキャリア市場を調査し、市場の概要、材料タイプ・用途・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場の成長要因
    • 細胞ベースのワクチンおよび治療薬の需要の高まり
    • 生物製剤およびバイオシミラー産業の急成長
    • 細胞治療研究のための研究開発と資金調達の増加
  • 市場の阻害要因
    • 生物製剤および細胞ベース治療のコストの高さ
    • 高密度マイクロキャリア培養の制限の拡大
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第5章 市場セグメンテーション

  • 材料タイプ別
    • アルギン酸塩ベース
    • コラーゲンベース
    • デキストランベース
    • ポリスチレンベース
    • その他
  • 用途別
    • 細胞療法
    • ワクチン製造
    • 生物製剤製造
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Danaher Corporation
    • Eppendorf AG
    • GE Healthcare
    • Lonza Group AG
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Hi-Media Laboratories

第7章 市場機会および将来動向

目次
Product Code: 64708

Market Overview

The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research.

Nearly a quarter of the current biologic pipeline is targeting the indications, which are small molecule dominated and have a large patient pool. This represents the trend of biologics entering non-traditional biologic disease areas, which could benefit from the increased therapeutic efficacy. Furthermore, this is also providing the room to the biosimilar market to grow.

In terms of medical efficacy, therapeutic spread, and population access biopharmaceuticals have vast potential, and much of this potential is still untapped. This potential can gradually be realized as manufacturing technologies, such as microcarrier based synthesis make progress, which may lead to commercialization of more effective therapies, increased manufacturing efficacy, and reduced therapy costs. Hence, owing to such rapid growth of the biologics and biosimilar industry, the market is positively affected.

Scope of the Report

A microcarrier is a support matrix, which allows the growth of adherent cells in bioreactors. In the large-scale commercial production of biologics and vaccines, microcarriers are employed to grow virus-generating or protein-producing adherent cell populations. As per the scope of the report, the microcarrier market includes various equipment and consumables, such as bioreactors, reagents, cell counters, and culture vessels in addition to microcarrier beads.

Key Market Trends

Cell Therapy is Expected to Show Fastest Growth in Application Segment

Microcarriers help in cost-effective cell production i.e they contribute to reducing fixed as well as variable costs during the large scale manufacturing. A few years back, it was suggested by the producers that microcarriers did not stand much helpful in cell production at a large scale as many of the microcarriers were made up of a solid matrix that required a microcarrier to be separated from the dissociated cells during downstream processing. This separation step was very complex and expensive previously.

However, with technological advancements, the current scenario has changed and the significance of microcarriers in cell therapy has increased. For instance, dissolvable microcarriers are currently there in the market that is composed of cross-linked polysaccharide polymers that can be efficiently dissolved during the cell harvest step. As the microcarriers get completely dissolved, there is no need for the separation and simply, the downstream process goes well. Therefore, these microcarriers are considered as beneficial beads for large scale cell production or cell therapy application.

Along with the above-mentioned statements, another factor that is responsible for the growth of cell therapy applications of microcarriers is that companies are currently focusing on the provision of microcarriers that contribute in the large scale and cost-effective production. E.g. Corning Incorporated provides dissolvable microcarriers.

North America is Expected to Dominate the Market

North America region is believed to have the largest share in the microcarrier market. This is majorly due to the rising gene and cell therapy research in the region along with the associations that are supporting this research. For instance, the American Society of Gene and Cell Therapy is responsible for the funding of the research and also, this society is forcing the biopharmaceutical and biotech companies to improve their R&D.

Along with that, the United States is witnessing high and rapid growth in the biologics and biosimilar Industry which is one of the major factor driving the microcarrier market in this region.

Competitive Landscape

The Microcarrier market is mostly inclusive of the global players and few companies that are currently dominating the market include Thermo Fisher Scientific, Sartorius AG, Eppendorf AG, Danaher Corporation (Pall Corporation), and GE Healthcare. The competition in the market is expected to increase as new companies are also coming up in the market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Cell-based Vaccines and Therapeutics
    • 4.2.2 Rapid Growth of Biologics and Biosimilar Industry
    • 4.2.3 Increasing R&D and Availability of Funding for Cell Therapy Research
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Biologics and Cell-based Therapies
    • 4.3.2 Growth Limitations of High Density Microcarrier Cultures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Material Type
    • 5.1.1 Alginate-Based
    • 5.1.2 Collagen-Based
    • 5.1.3 Dextran-Based
    • 5.1.4 Polystyrene-Based
    • 5.1.5 Others
  • 5.2 By Application
    • 5.2.1 Cell Therapy
    • 5.2.2 Vaccine Manufacturing
    • 5.2.3 Biologics Manufacturing
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Danaher Corporation
    • 6.1.2 Eppendorf AG
    • 6.1.3 GE Healthcare
    • 6.1.4 Lonza Group AG
    • 6.1.5 Merck KGaA
    • 6.1.6 Thermo Fisher Scientific Inc.
    • 6.1.7 Hi-Media Laboratories

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top